An artificial intelligence system has sifted through 410,198 Reddit posts to map how people describe side effects from the blockbuster GLP-1 drugs semaglutide and tirzepatide. The peer-reviewed analysis, which identified 67,008 self-reported users and found that 43.5% mentioned at least one side effect, suggests that some symptom patterns may not be fully captured in formal trials. For patients and clinicians trying to judge the tradeoffs of drugs like Ozempic, the work raises immediate questions about what might be missing from official labels and traditional safety databases.
Why an AI combed 410,198 Reddit posts matters now
The core finding is scale. In a peer-reviewed study in the journal Nature Health, researchers analyzed 410,198 posts from Reddit written between May 2019 and June 2025 that mentioned GLP-1 medications such as semaglutide and tirzepatide, according to Nature Health. Within that firehose of conversation, they identified 67,008 people who appeared to be self-reporting their own use of these drugs, which created a dataset far larger than a typical clinical trial.
Among those self-identified users, 43.5% described at least one side effect in their posts, according to the same Nature Health analysis. That figure matters because it reflects how people talk about their bodies outside a clinic visit, rather than how they respond to structured questionnaires. Known side effects such as nausea and vomiting showed up frequently, which the researchers described as a way to validate that the Reddit signal aligns with established safety data.
The tension comes from what sat alongside those expected complaints. The Nature Health paper reports that certain symptom categories, including reproductive and menstrual changes, appeared more often in Reddit posts than in formal trial summaries or drug labels. That gap suggests that online chatter can generate early leads about patterns that regulators and manufacturers have not yet fully characterized, even if those patterns still need careful confirmation.
The timing is sensitive because GLP-1 drugs have moved from niche diabetes treatments into mass-market weight loss tools, yet the official safety picture is still built on controlled populations. As more people with different medical histories use these medications, the Reddit data hints that real-world experiences may be broader than what pre-approval trials captured.
The evidence behind the AI Reddit study
The Nature Health paper, titled “Self-reported side effects of semaglutide and tirzepatide in online communities,” is the main scientific record behind the Reddit findings, according to the journal’s peer-reviewed study. The authors used natural language processing to scan posts on Reddit and then built classifiers to decide which posts came from people who said they were using GLP-1 drugs themselves, and which sentences described side effects.
A preprint version of the same work on medRxiv lays out more of the machinery behind that process. The preprint explains how the team defined the Reddit cohort, how the model tagged user posts as “use” versus other discussion, and how symptoms were extracted and normalized across different phrasings, according to the medRxiv document. It also describes sensitivity checks that tested whether the AI pipeline misclassified common slang or sarcasm.
The Nature Health article reports that the final dataset covered 410,198 posts from May 2019 through June 2025 and that 67,008 Reddit accounts were labeled as self-reported GLP-1 users. Within this group, 43.5% mentioned at least one side effect. The authors grouped these symptoms into classes that match or extend beyond those in clinical trials, with a specific note that reproductive and menstrual complaints appeared to be underrepresented in existing trial reports and labels.
The institutional statement from the University of Pennsylvania adds context from the researchers themselves. The release notes that well known side effects like nausea appeared often in the Reddit data, which the team said helped confirm that their AI pipeline was picking up real drug experiences, according to the institutional summary. That same statement cites a statistic that nearly 4% of self-reported users mentioned menstrual irregularities, which the researchers framed not as proof of a new side effect but as a signal that deserves closer study.
The researchers stressed that correlation in Reddit posts does not prove causation. People who write about using semaglutide or tirzepatide may also have other medical conditions, take other medications, or misattribute unrelated symptoms to the drug. The Nature Health paper treats these online reports as hypothesis generators, not as a replacement for controlled studies.
To explain why this approach matters for drug safety, the authors point to how regulators typically track problems once a drug is on the market. The U.S. Food and Drug Administration maintains the FDA Adverse Event Reporting System, or FAERS, which is described as a post marketing safety surveillance database that collects voluntary reports from clinicians, patients, and manufacturers, according to the FAERS dataset. These reports feed into signal detection, label changes, and sometimes new warnings.
The FDA also offers the Adverse Event Monitoring System Public Dashboard, a web interface that lets the public query aggregated adverse event data and that the agency describes as a modernized front end for what was previously called the FAERS Public Dashboard, according to the agency’s dashboard description. The dashboard explains that spontaneous reports have known limitations, including underreporting and variable detail. Against that backdrop, the Reddit analysis positions large scale social media mining as a complementary stream that might surface patterns earlier or in more granular language.
What remains unresolved about AI-mined GLP-1 side effects
Even with hundreds of thousands of posts, the Reddit study leaves major questions open. The Nature Health paper explicitly states that online self reports cannot prove that a drug caused a given symptom. Without medical records, lab results, or clinician assessment, there is no way to separate drug effects from underlying disease or from unrelated events that happened during treatment, according to the journal access page that links to the study.
Selection bias is another unresolved issue. People who feel unwell or frustrated may be more likely to post on Reddit than those who tolerate a drug without problems. That skew could inflate the apparent rate of side effects compared with structured follow up in a trial. The 43.5% figure for users mentioning at least one side effect reflects what is written in this particular online community, not a population wide incidence rate.
There are also gaps in how well the AI can interpret context. The medRxiv preprint describes classifier choices and sensitivity analyses, but any automated system risks misreading sarcasm, misclassifying jokes as symptoms, or missing subtle descriptions that do not fit a predefined symptom dictionary, according to the preprint. That means some symptom classes might be overcounted while others are missed.
On the regulatory side, the relationship between social media mining and official safety tools is still unsettled. The FDA materials on FAERS and the AEMS Public Dashboard describe an evolving set of systems for collecting and presenting adverse event data, but they do not spell out how or whether large scale social media analyses will feed into routine signal detection, according to the agency’s surveillance guidance. For now, Reddit based findings sit outside the formal structures that drive label changes.
For patients and clinicians, the practical takeaway is not to treat every Reddit anecdote as proof of harm, but also not to ignore recurring patterns that appear across tens of thousands of posts. The researchers and the University of Pennsylvania statement both present underreported symptom classes, such as menstrual irregularities, as leads that should prompt more targeted studies and closer questioning during visits, according to the institutional release.
The next thing to watch is whether regulators, drug makers, or health systems begin to fold social media analytics into their standard safety workflows alongside FAERS and AEMS. If that happens, the kind of AI that combed 410,198 Reddit posts could shift from an academic experiment into a routine early warning tool, narrowing the gap between what patients say online and what appears on an official drug label.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
